Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

If he’s confirmed as health secretary, Robert F. Kennedy Jr. will have broad authority to pursue an anti-vaccine agenda.

R.F.K. Jr. and others have blamed the ingredient for allergies and other illnesses. Scientists say it actually bolsters the ...

Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...